Sign in
Active, not recruitingNo phase

PAN-ICIS Study: ICIS for Early Detection of Infectious Complications in Pancreatic Surgery

Key facts

Who runs it
Charles University, Czech Republic
Where
Czechia1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
400 people, planned
Started
1 Nov 2025
Expected to end
31 Mar 2028
Type of study
Observational
Record updated
1 December 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (6)Hide the full registry criteria

Who can take part

  • Patients ≥ 18-years-old
  • Indication for an elective pancreatic procedure
  • Written informed consent

Who cannot take part

  • Known hematologic malignancy or hematological pathology
  • Patients <18 years old
  • Refusal to participate

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study examines a new blood test called ICIS, which may help detect infections earlier after pancreatic surgery. Patients will have routine blood samples taken during their hospital stay, with no extra procedures required. By tracking how ICIS changes over time, investigators aim to improve early infection detection, support safer recovery, and reduce postoperative complications.

The group in the trial

  • Patients following pancreatic surgery

    All patients following pancreatic surgery will be enrolled in this study

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
PAN-ICIS: Prospective Observational Study Evaluating the Intensive Care Infection Score for Early Detection of Infectious Complications After Pancreatic Resections
Record updated
1 December 2025